We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pennsylvania’s attorney general filed a new lawsuit on Wednesday against Purdue alleging that the drugmaker sent a torrent of sales representatives to convince doctors in the state to prescribe OxyContin. Read More
A Trump administration directive aimed at keeping the FDA out of the death penalty debate may have pushed the agency right into the thick of it—and may even force drug companies to compel the agency to step in. Read More
Under the new DOJ guidelines, companies can earn “points” for disclosing potential fraud early, or for “meaningful assistance” in an investigation. Read More
The approval comes after Roche presented results from a Phase III trial, which reduced the risk of breast cancer coming back by half in patients in the Kadcyla group. Read More
The FDA’s cancer drug advisory committee voted Tuesday on two new treatments from Daiichi Sankyo—backing one while giving the thumbs down for the other. Read More
AbbVie has settled its lawsuit with Boehringer Ingelheim, the last domino to fall in an all-out patent war that will protect AbbVie’s mega-blockbuster Humira until 2023. Read More